gurufocus.comOCT 82 min read$XP

XP Maintains Buy Rating -- Price Target Raised to $37.00 by UBS

UBS raised its price target for XP Inc. from $25.00 to $37.00, maintaining a Buy rating. The stock is currently trading at $30.60, which is 36.1% above its GF Value™ of $22.48, according to GuruFocus. XP has a GF Score™ of 87/100, indicating strong performance, but also shows significant insider selling.

Original reporting

gurufocus.com

Published Oct 8, 2026, 6:33 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 8, 2026, 7:00 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefFinancial news

Primary signal

$XP

Bullish

high confidence

Mentioned

$XP

Relevance

7/10

AlphAI data visualization · based on gurufocus.com

Decision brief

The 30-second read

$XPBullishMed

Why it matters

The UBS rating upgrade provides a fresh catalyst that could attract new buying, but insider sell‑off and valuation premium temper enthusiasm.

Market read

Analyst upgrade is a primary corporate event that may move XP's share price in the short term.

What to watch

Recent insider selling of $2.4 M could signal downside risk despite the upgrade.

Relevance 7/10Novelty 7/10Timing: today

Background

XP Inc. is a technology-driven financial services platform in Brazil with a market cap of ~$15.8 B.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$XPBullishHigh confidence

Context

UBS maintains Buy rating on XP and raises price target from $25 to $37, indicating fresh analyst upgrade.

Expected impact

likely upward pressure as investors price in the new target

Evidence & confidence

The rating change is a primary disclosure and the target increase is sizable (48%).

Market effects

Sector

May lift sentiment in Brazil's financial services sector.

Regional

Potentially supportive for broader Latin American equities.

Global

Limited to investors focused on emerging market financial stocks.

Counterpoint

What could challenge this read

The stock appears overvalued at $30.60 versus intrinsic $22.48, suggesting caution.

Key entities

company
XP Inc.
Brazilian financial services platform listed on NYSE under ticker XP.
analyst_firm
UBS
Provided the rating upgrade and new price target.

Read at source ← All news

OCT 5

$PTCHighAI 9/10

Nasdaq 100 Hits Record, Brazil ETF EWZ Soars 13% - Nu Holdings (NYSE:NU)

The Nasdaq 100 hit a record high, while the iShares MSCI Brazil ETF (EWZ) surged 13.5% following Brazil's election results. The S&P 500 gained 0.5%, and the 10-year Treasury yield rose to 5.33%. Nu Holdings (NU) rose 13% amid the Brazil rally.

benzinga.com3 min

OCT 5

$XPMedAI 8/10

XP Stock Soars 33% to Yearly High as Flávio Bolsonaro's Surprise Lead Sparks Rally in Brazilian Markets

XP Inc. shares rose 33% to a 52-week high after Flávio Bolsonaro led Brazil's presidential election first round, outperforming polls. The stock reached $28.69, lifting market value to $14.5B. Investors favor Bolsonaro's fiscal policies over Lula's, benefiting XP, a major Brazilian investment platform.

ibtimes.com.au3 min

SEP 19

$XPMed

Brazil Fintech Stocks Fall in New York After Nubank Downgrade

Brazilian fintech stocks listed in New York, including Nubank, fell 2.55% to 8.57% from 14 to 18 September, driven by a downgrade from Itaú BBA and a US rate hike. Nubank's target price was cut to $18, citing slower profit growth. XP, less reliant on consumer lending, rose 4%. Political and economic risks also weighed on the sector.

riotimesonline.com3 min

SEP 2

$XPMed

XP jumps as strong Q2 results, share cancellation, and a fresh analyst upgrade lift sentiment

XP Inc. (XP) shares rose 6.2% following strong Q2 results, including 8% revenue growth to R$5.1B, 9% net revenue growth to R$4.9B, and 9% EPS growth to R$2.67. The company also canceled 11.8M Class A treasury shares, reducing share count by 2.3%. Analyst Itau BBA upgraded the stock to Outperform with a $22 target.

quiverquant.com2 min

SEP 1

$XPMedAI 8/10

XP (XP) Is Up 6.8% After Q2 2026 Earnings Beat With Revenue And EPS Both Rising

XP Inc. reported Q2 2026 results with revenue of R$4,849 million, net income of R$1,384 million, and EPS of R$2.67, all up year-over-year. The company is executing share buybacks and faces competition and fee pressure risks. Analysts' 2029 revenue and earnings estimates range from R$24.5B to R$25.8B and R$7.1B to R$7.2B, respectively.

simplywall.st2 min

AUG 31

$DEMed

This Deere Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Deere (NYSE:DE), XP (NASDAQ:XP)

Baird upgraded Deere (NYSE:DE) to Outperform, raising its price target to $800 from $640. Itau BBA upgraded XP Inc. (NASDAQ:XP) to Outperform with a $22 target. Baird also upgraded AGCO (NYSE:AGCO) to Outperform, lifting its target to $150 from $120. Argus upgraded Abercrombie & Fitch (NYSE:ANF) to Buy with a $162 target. UBS upgraded Kaiser Aluminum (NASDAQ:KALU) to Buy, raising its target to $184 from $179.

benzinga.com2 min